« previous next »
Pages: [1]   Go Down

Author Topic: Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models  (Read 75 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models
« on: August 02, 2024, 01:50:52 PM »
Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity.
Source: Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models
« on: August 02, 2024, 01:50:52 PM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal